Month: January 2026

Winter Olympics Trends Small Brands Can Capitalize On

Written by Customer Service on January 28, 2026. Posted in Public Companies.

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) — As the Milan Cortina 2026 Winter Olympics and Paralympics approach, new research from iStock, a leading ecommerce platform providing premium content to SMBs, SMEs, creatives, and students everywhere, suggests the biggest shift isn’t in how sport is played— but in how it’s experienced, interpreted and translated into culture. According to new insights from iStock’s VisualGPS research platform, consumers don’t just watch major sporting events for competition. Events like the Winter Games are becoming cultural moments, where identity, authenticity and personal values shape attention just as much as medals do. VisualGPS found that nearly 6 in 10 consumers worldwide believe athletes should be free to express their full identity beyond the field of play. For brands, this means audiences still...

SOLOWIN HOLDINGS’s AX Coin Becomes the First Stablecoin Issuer Granted In-Principle License Approval from the Central Bank of Bahrain

Written by Customer Service on January 28, 2026. Posted in Public Companies.

Bahrain, Manama, Jan. 28, 2026 (GLOBE NEWSWIRE) — SOLOWIN HOLDINGS (NASDAQ: AXG) (“AXG” or the “Company”), a leading financial technology firm bridging traditional and digital assets, today announced that AX Coin, the stablecoin issuance entity under AlloyX Group, a key subsidiary of the Company, has received an In-Principle Approval letter for a stablecoin license from the Central Bank of Bahrain (“CBB”), subject to final regulatory approval. Dr. Thomas Zhu, Co-Founder and Chief Executive Officer of AlloyX Group, commented: “We would like to express our gratitude to the Central Bank of Bahrain for its guidance over the past six months. We look forward to launching a compliant stablecoin within the regulatory framework and driving the development of AlloyX Group’s stablecoin ecosystem across the Middle East and Africa (MEA)...

Rover Group Acquires Cat-Centric Marketplace, Meowtel

Written by Customer Service on January 28, 2026. Posted in Mergers And Acquisitions.

Together Rover and Meowtel Will Make it Easier For Pet Parents to Connect with Experienced Cat Sitters SEATTLE, Jan. 28, 2026 (GLOBE NEWSWIRE) — Rover Group, Inc., the world’s largest online marketplace for pet care, today announced it has acquired Meowtel Inc., the No. 1 cat sitting marketplace trusted by thousands of cat lovers across America. With this transaction, Rover accelerates its existing investment in cat-centric care for pet parents. Founded in 2015, Meowtel has grown its active cat-sitting community to over 4,000 providers, serving more than 125,000 cats in over 8,000 cities across the country. With deep mission alignment – making it easier for people to experience the unconditional love of pets – Rover will serve as an accelerant to Meowtel, helping the platform scale its ability to meet the unique needs of cat parents. “Rover...

Lakeland Fire + Safety Secures Tender from Belgian Federal and Local Police Departments for Safety Footwear

Written by Customer Service on January 28, 2026. Posted in Public Companies.

Third Award in Six-Year Tender Agreement Demonstrates Global Reach Across Industry Verticals HUNTSVILLE, Ala., Jan. 28, 2026 (GLOBE NEWSWIRE) — Lakeland Industries, Inc. (“Lakeland Fire + Safety” or “Lakeland”) (NASDAQ: LAKE), a leading global manufacturer of protective clothing and apparel for industry, healthcare and first responders, today announced it has received an order from the Belgian Federal Police and Local Police departments for certified safety footwear. Terms of the order were not disclosed. The Belgian Federal Police force carries out specialized and supra-local administrative and judicial police operations, supporting both local and federal police services and units, and has approximately 12,300 officers and civilian personnel. Belgium is subdivided into 196 local police areas, with approximately...

Perella Weinberg to Announce Full Year and Fourth Quarter 2025 Financial Results and to Host Conference Call on February 6, 2026

Written by Customer Service on January 28, 2026. Posted in Public Companies.

NEW YORK, Jan. 28, 2026 (GLOBE NEWSWIRE) — Perella Weinberg Partners (NASDAQ:PWP), a leading global independent advisory firm, today announced that it plans to release its financial results for the full year and fourth quarter 2025 on Friday, February 6, 2026, before the market opens. Conference Call and Webcast Management will host a conference call and webcast to review Perella Weinberg’s results on the same day at 9:00AM ET. A webcast of the conference call will be available to the public on a listen-only basis and can be accessed through the Investors section of the Company’s website at https://investors.pwpartners.com. The conference call can also be accessed by the following dial-in information:Domestic: (800) 245-3047 International: (203) 518-9765 Conference ID: PWPQ425Replay A replay of the call will also be available...

GRI Bio Delivers Compelling New Phase 2a Gene Expression Data Demonstrating Improvements in Key Drivers of Fibrosis and Lung Repair in IPF

Written by Customer Service on January 28, 2026. Posted in Public Companies.

Multiple Independent Molecular Signals Converge to Validate GRI-0621 as a Potential Disease-Modifying Therapy LA JOLLA, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) — GRI Bio, Inc. (NASDAQ: GRI) (“GRI Bio” or the “Company”), a biotechnology company advancing an innovative pipeline of immune cell modulators for the treatment of inflammatory, fibrotic and autoimmune diseases, today announced additional positive data from its recently completed Phase 2a clinical study of GRI-0621 in Idiopathic Pulmonary Fibrosis (“IPF”), further strengthening potential clinical proof-of-concept and reinforcing the therapeutic differentiation of GRI-0621. Newly reported RNA-sequencing differential gene expression data demonstrate that treatment with GRI-0621 resulted in significant improvement across genes associated with lung injury, myofibroblast activation,...

PDS Biotech Announces Presentation of Preliminary Results from Phase 2 Study of IL-12 Tumor Targeted Immunocytokine (PDS01ADC) in 3rd Line Metastatic Castration Resistant Prostate Cancer by the NCI

Written by Customer Service on January 28, 2026. Posted in Public Companies.

NCI-Led Study Shows Median PFS of 9.6 Months Results Presented at AACR Special Conference on Innovations in Prostate Cancer PRINCETON, N.J., Jan. 28, 2026 (GLOBE NEWSWIRE) — PDS Biotechnology Corporation (Nasdaq: PDSB) (“PDS Biotech” or the “Company”), a late-stage immunotherapy company focused on transforming how the immune system targets and kills cancers, today announced that results of a National Cancer Institute (“NCI”)-led study of the Company’s investigational Interleukin-12 (IL-12) tumor targeted immunocytokine, PDS01ADC, were presented at the American Association of Cancer Research (“AACR”) special conference on prostate cancer research, held in Boston, MA on January 20-22, 2026. The study, titled Docetaxel and the Tumor-Targeting Interleukin-12 (“IL-12”) PDS01ADC in Patients with Metastatic Castration-Resistant Prostate...

Powering Smarter Utilities: Itron Deepens Strategic AI Collaboration with Microsoft

Written by Customer Service on January 28, 2026. Posted in Public Companies.

New Intelligent Edge Operating System Copilot Connector Empowers Utilities to Achieve New Levels of Efficiency LIBERTY LAKE, Wash., Jan. 28, 2026 (GLOBE NEWSWIRE) — Itron, Inc. (NASDAQ: ITRI), which is innovating new ways for utilities and cities to manage energy and water, is deepening its long-standing collaboration with Microsoft to accelerate AI innovation at the edge, delivering solutions that empower utilities to achieve new levels of efficiency, resilience and customer engagement. Building on years of joint work across cloud, analytics and grid modernization, this expanded AI collaboration brings together Itron’s expertise in energy and water management with Microsoft’s advanced AI capabilities, reinforcing their shared commitment to leading the AI transformation in the utility industry. As part of this ongoing collaboration,...

Immix Biopharma Receives U.S. FDA Breakthrough Therapy Designation for NXC-201

Written by Customer Service on January 28, 2026. Posted in Public Companies.

– Breakthrough Therapy Designation granted to NXC-201 based on positive NEXICART-2 Phase 2 interim clinical results, presented at the American Society of Hematology (ASH) 2025 annual meeting – – Final data expected this year followed by planned BLA submission – LOS ANGELES, CA, Jan. 28, 2026 (GLOBE NEWSWIRE) — Immix Biopharma, Inc. (“ImmixBio”, “Company”, “We” or “Us” or ”IMMX”), the global leader in relapsed/refractory AL Amyloidosis, today announced that the U.S. Food and Drug Administration (FDA) has granted Breakthrough Therapy Designation to NXC-201 for the treatment of relapsed/refractory AL Amyloidosis. Per FDA, Breakthrough Therapy designation aims to expedite the development and review of drugs that are intended to treat a serious condition and preliminary clinical evidence indicates that the drug may demonstrate substantial...

Strive Announces Closing of Upsized & Oversubscribed Follow-On Offering of SATA Stock and Concurrent Exchange of Semler Notes

Written by Customer Service on January 28, 2026. Posted in Public Companies.

DALLAS, Jan. 28, 2026 (GLOBE NEWSWIRE) — Strive, Inc. (Nasdaq: ASST; SATA) (“Strive” or the “Company”) today announced the closing of its follow-on offering (the “offering”) of 1,320,000 shares of Strive’s Variable Rate Series A Perpetual Preferred Stock (the “SATA Stock”), at a public offering price of $90 per share. The Company announced over $600 million in demand for the SATA Stock from the follow-on offering and upsized the initial $150 million target raise to $225 million, when taken together with the concurrent privately negotiated notes exchanges described below. As described below, the Company has now retired $110 million of the $120 million aggregate principal amount of debt the Company assumed from the Semler Scientific, Inc. (“Semler Scientific”) acquisition. The Company also announced its intention to retire the remaining...

Month: January 2026

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals